US Senator again asks drug makers to explain why US prices are so high
This article was originally published in Scrip
Executive Summary
Senator Herb Kohl, chairman of the US Senate special committee on ageing and Wisconsin Democrat, recently sent letters to drug makers including Pfizer, Lilly, AstraZeneca and GlaxoSmithKline, asking them to explain why Americans pay an average of twice as much for prescription drugs as people in other industrialised nations, when, as he asserts, "the bulk of drug research and innovation happens here in the US and much of it is subsidised by the federal government".